Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Blood sugar reducing tablet containing inonotus obliquus and preparation method of blood sugar reducing tablet

A Chaga mushroom, hypoglycemic technology, which is applied in the directions of medical preparations containing active ingredients, pill delivery, pharmaceutical formulations, etc., can solve the problems of poor Chaga mushroom taste and insignificant hypoglycemic effect, and achieve the effect of lowering blood sugar.

Inactive Publication Date: 2019-10-15
张宇锋
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The present invention aims to solve the technical problems that the taste of edible chaga is poor and the effect of lowering blood sugar is not significant, and provides a tablet containing chaga for lowering blood sugar and a preparation method thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0027] Specific Embodiment 1: In this embodiment, a hypoglycemic tablet containing chaga contains 88 to 92 parts by mass of Chaga, 0.8 to 1.2 parts of ginseng, 0.8 to 1.2 parts of chicory and 7 to 9 parts of malt paste Refined.

specific Embodiment approach 2

[0028] Specific embodiment two: the difference between this embodiment and specific embodiment one is: the described a kind of chaga-containing hypoglycemic tablet comprises 90 parts of chaga, 1.0 part of ginseng, 1.0 part of chicory and 8 parts maltodextrin. Others are the same as in the first embodiment.

specific Embodiment approach 3

[0029] Specific embodiment three: In this embodiment, a preparation method of chaga-containing blood sugar-lowering tablet is prepared according to the following steps:

[0030] 1. Weigh 88-92 parts of chaga, 0.8-1.2 parts of ginseng, 0.8-1.2 parts of chicory and 7-9 parts of maltodextrin according to the parts by mass;

[0031] 2. Roll the chaga, ginseng, chicory and maltodextrin weighed in step 1 into powder, then sieve and mix evenly to obtain a mixed powder;

[0032] 3. The mixed powder obtained in step 2 is sterilized by radiation and sprayed with a wetting agent to obtain a soft material;

[0033] 4. The soft material obtained in step 3 is granulated, then spread evenly, and dried to obtain pre-granulated;

[0034] 5. Sieve the pre-manufactured granules obtained in step 4, and then compress into tablets to obtain the chaga-containing hypoglycemic tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Hardnessaaaaaaaaaa
Hardnessaaaaaaaaaa
Login to View More

Abstract

The invention discloses a blood sugar reducing tablet containing inonotus obliquus and a preparation method of the blood sugar reducing tablet, and relates to the field of blood sugar reducing medicament. The technical problems that the taste of current edible inonotus obliquus is poor and a blood surgar reducing effect is not obvious are solved. The blood sugar reducing tablet containing inonotusobliquus includes the following components: the inonotus obliquus, radix ginseng, herba cichorii and maltodextrin. The preparation method comprises the following steps: weighing the raw materials; grinding the raw materials into powder; granulating the powder; and performing pressing to obtain the tablet. According to a formula of the blood sugar reducing tablet disclosed by invention, the inonotus obliquus, the radix ginseng and the herba cichorii are combined through the maltodextrin, and thus, the tablet is prepared. The problem that the taste of the inonotus obliquus is bitter when the inonotus obliquus is directly eaten is solved; and active ingredients of the tablet complement each other, so that a synergistic effect is produced, insulin secretion is promoted, the sensitivity of glucose on the insulin is enhanced, the lipid metabolism is improved, and the good blood sugar reducing effect is achieved. The processing technology is simple, proportions of components are reasonably controlled; and the prepared tablet is convenient to carry and orally take, and is clear in dosage. The blood sugar reducing tablet containing the inonotus obliquus disclosed by the invention is used for reducing the blood sugar.

Description

technical field [0001] The invention relates to the field of hypoglycemic agents. Background technique [0002] The normal value of fasting blood glucose is below 6.1mmol / L, and the normal value of blood glucose two hours after a meal is below 7.8mmol / L. If the blood glucose is higher than these two ranges, it is called hyperglycemia. Under normal circumstances, the human body can ensure the balance between the source and outlet of blood sugar through the two major regulatory systems of hormone regulation and nerve regulation, so that blood sugar can be maintained at a certain level. However, under the joint action of genetic factors (such as family history of diabetes) and environmental factors (such as unreasonable diet, obesity, etc.), the two major regulatory functions are disturbed, and blood sugar levels will rise. [0003] Short-term, one-time hyperglycemia has no serious damage to the human body. For example, in a state of stress or emotional agitation or high tens...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/28A61K9/20A61K47/36A61P3/10
CPCA61K9/2059A61K36/07A61K36/258A61K36/28A61P3/10A61K2300/00
Inventor 张宇锋
Owner 张宇锋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com